The TTN and AChR-α epitope presence in NEFM was previously described by Marx and colleagues [28,29], suggesting molecular mimicry as a putative mechanism for anti-AChR and anti-TTN autosensitization in thymomatous MG patients. The gene discussed is CHRNA1; the disease is myasthenia gravis.